Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors
Fluorescence in situ hybridization (FISH) is a standard technique used in routine diagnostics of genetic aberrations. Thanks to simple FISH procedure is possible to recognize tumor-specific abnormality. Its applications are limited to designed probe type. Gene rearrangements e.g., <i>ALK</i...
Main Authors: | Natalia Magdalena Chrzanowska, Janusz Kowalewski, Marzena Anna Lewandowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/8/1864 |
Similar Items
-
Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer
by: Sara S. Fois, et al.
Published: (2021-01-01) -
Later-Line Treatment with Lorlatinib in <i>ALK</i>- and <i>ROS1</i>-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis
by: Maximilian J. Hochmair, et al.
Published: (2020-11-01) -
Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing
by: Annabell Szymansky, et al.
Published: (2021-07-01) -
Emerging Roles of ALK in Immunity and Insights for Immunotherapy
by: Lan Wang, et al.
Published: (2020-02-01) -
Detecting Resistance to Therapeutic ALK Inhibitors in Tumor Tissue and Liquid Biopsy Markers: An Update to a Clinical Routine Practice
by: Paul Hofman
Published: (2021-01-01)